Siemens is launching its Enhanced Liver Fibrosis (ELF) diagnostic in the U.S. this week to help test patients with chronic liver disease. This new testing service comes out of the Siemens Healthcare ...

The Enhanced Liver Fibrosis (ELF) is the first prognostic tool for patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to be granted De Novo marketing authorization.

Disclaimer: The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. In the U.S., the ELF Test is indicated as a ...

TARRYTOWN, N.Y.--(BUSINESS WIRE)--The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive ...

An intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary care system reduced unnecessary specialist referrals over a 5-year period, and improved triage for ...

At present, transient elastography and the serum marker FibroTest are the most intensively evaluated non-invasive methods for the assessment of liver fibrosis. The results of the present study for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Enhanced liver fibrosis score was found ...